UNSPSC 51334402: Biriperone

This classification denotes an anxiolytic with the molecular formula C24H26FN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5776HBV7UD, chemically known as pyrazino(1,2:1,6)pyrido(3,4-b)indole, 1,2,3,4,6,7,12,12a-octahydro-2-(3-(p-fluorobenzoyl)propyl)-, dl- but generally known as biriperone, which bears US NIH Compound Identifier 68663. European Medicines Agency schedules Biriperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05845MIG.

UNSPSC 51334402 Biriperone, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS—solicits naloxone and safe drug deactivation systems for community health support, a scope entirely unrelated to biriperone (a pharmaceutical intermediate compound). The code shows little relevant recent activity under its nominal definition. Biriperone procurement, if pursued by state and local governments, does not appear in current solicitation records and is not characterized by identifiable patterns of issuing bodies or geographic concentration among counties, cities, school districts, or other jurisdictions.

The mismatch between code and opportunity suggests either a cataloging error in the source data or a jurisdictional tagging inconsistency. Seminole County's procurement—an IFB with a response deadline of July 26, 2023, for quarterly deliveries of naloxone and drug deactivation systems to the Seminole County Community Health Building in Sanford, Florida—falls outside biriperone's typical use case. Business development professionals evaluating this code should expect to find no actionable opportunities under the biriperone commodity definition in current state and local markets and should verify code assignment before pursuing related solicitations.